4//SEC Filing
Nunes Anne 4
Accession 0001171843-25-001470
CIK 0000898437other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:19 PM ET
Size
9.2 KB
Accession
0001171843-25-001470
Insider Transaction Report
Form 4
Nunes Anne
SVP, Chief Operations Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-11+2,561→ 18,837 total - Tax Payment
Common Stock
2025-03-11$16.79/sh−752$12,626→ 18,085 total - Exercise/Conversion
Restricted Stock Unit
2025-03-11−2,561→ 0 totalExercise: $0.00→ Common Stock (2,561 underlying)
Footnotes (4)
- [F1]Reflects the third and final vesting installment of RSUs granted on March 11, 2022.
- [F2]Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025.
- [F3]Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations.
- [F4]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001982862
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:19 PM ET
- Size
- 9.2 KB